Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
acetylcysteine (mucomyst) (1 trial)
sufentanil (1 trial)
Deafness (Phase 1)
Hearing Loss (Phase 1)
Hearing Loss, Noise-Induced (Phase 1)
Hearing Loss, Sensorineural (Phase 1)
Trials (1 total)
Trial APIs (2 total)